IVS-5001

N/A

Report date: 2025/01/26 15:56:34

Base Information

Drug NameIVS-5001
Drug Alias NameLILRB2 immune checkpoint inhibitor (Invectys)IVS-5001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLeukocyte immunoglobulin-like receptor subfamily B member 4 inhibitors
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 4
Therapy Area/IndicationsSolid tumoursGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInvectys SAS
China Registration ClassN/A

Develop Information

Active CompaniesInvectys SAS
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A